FOR CLINICAL RESEARCH

Duchenne Hub UK was established in 2016 as a partnership between Duchenne UK and the John Walton Muscular Dystrophy Research Centre at Newcastle University.

Duchenne Hub UK brings together a group of clinical trial sites that have dedicated, trained staff, funded to carry out clinical research for Duchenne muscular dystrophy.

About Duchenne Hub UK

Duchenne Hub UK was set up because trials are important for finding new treatment options for people with Duchenne – and supporting the development of research into new treatments.

Before the Hub was launched, clinical trials for Duchenne were only conducted at Great Ormond Street Hospital (GOSH) in London and the Newcastle-upon-Tyne Hospital. These sites were working at full capacity and we discovered they were turning away trials from drug companies. This meant that only a few clinical trials could be conducted for Duchenne and very few patients were able to participate in trials each year.

The IMPACT

Duchenne Hub UK now has a thriving network of
eleven clinical trial sites across England and Scotland, each funded and staffed to carry out Duchenne clinical trials and research studies.

83 trials

Helped run 83 trials accelerating the development of new treatments for Duchenne.

349 people

349 people have taken part in interventional clinical trials.

1,300 people

1,300 people have taken part in Duchenne research including interventional, open label extension, observational and natural history studies.

17

Partnered with 17 leading companies and 5 clinical research organisations, advancing Duchenne research.

Recruiting for a Clinical Trial?

If you’re planning a clinical trial for Duchenne in the UK, we’d love to hear from you.